Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Innoslate Reviews & Ratings
    4.5 out of 5 stars 99 Ratings
    Company Website for Innoslate
  • Azore CFD Reviews & Ratings
    4.3 out of 5 stars 26 Ratings
    Company Website for Azore CFD
  • JDisc Discovery Reviews & Ratings
    4.8 out of 5 stars 30 Ratings
    Company Website for JDisc Discovery
  • Cloverleaf Reviews & Ratings
    4.8 out of 5 stars 189 Ratings
    Company Website for Cloverleaf
  • Criminal IP ASM Reviews & Ratings
    4.9 out of 5 stars 21 Ratings
    Company Website for Criminal IP ASM
  • Jama Connect Reviews & Ratings
    4.3 out of 5 stars 416 Ratings
    Company Website for Jama Connect
  • AthenaHQ Reviews & Ratings
    4.9 out of 5 stars 41 Ratings
    Company Website for AthenaHQ
  • Digital WarRoom Reviews & Ratings
    4.6 out of 5 stars 55 Ratings
    Company Website for Digital WarRoom
  • FrameworkLTC Reviews & Ratings
    4.4 out of 5 stars 48 Ratings
    Company Website for FrameworkLTC
  • LTX Reviews & Ratings
    4.4 out of 5 stars 182 Ratings
    Company Website for LTX

What is Schrödinger?

Transform the domains of drug development and materials science by employing advanced molecular modeling approaches. Our computational platform, rooted in the principles of physics, offers distinct solutions for predictive modeling, data analysis, and collaborative efforts, enabling efficient exploration of chemical space. This state-of-the-art platform is utilized by top industries worldwide, supporting drug discovery projects and materials science endeavors in diverse fields such as aerospace, energy, semiconductors, and electronic displays. It propels our internal drug discovery initiatives, managing the entire process from identifying targets to discovering hits and optimizing leads. Moreover, it boosts our collaborative research aimed at developing innovative medicines to tackle major public health issues. With a dedicated team comprising over 150 Ph.D. scientists, we invest considerable resources into research and development. Our impact on the scientific community is highlighted by over 400 peer-reviewed publications that demonstrate the effectiveness of our physics-based approaches, ensuring we remain leaders in the evolution of computational modeling techniques. We are unwavering in our commitment to pioneering advancements and broadening the horizons of our industry while fostering partnerships that amplify our research capabilities.

What is Healnet?

The realm of rare diseases frequently suffers from inadequate research, leading to a lack of vital insights necessary for successful drug discovery efforts. Our advanced AI platform, Healnet, tackles these challenges by analyzing extensive datasets related to drugs and diseases, revealing novel connections that could pave the way for new treatment options. By employing state-of-the-art technologies during both the discovery and development stages, we can manage several phases at once and on a considerable scale. The traditional methodology, which usually concentrates on one disease, target, and drug, is an overly simplistic model that many pharmaceutical companies continue to follow. The upcoming era of drug discovery is set to be revolutionized by AI, which emphasizes concurrent operations and a flexibility that allows for exploration beyond rigid hypotheses, effectively merging the three fundamental aspects of drug discovery into a unified approach. This innovative framework not only boosts productivity but also encourages inventive thinking in addressing intricate health issues. As we move forward, the integration of AI in drug development will likely reshape how the industry approaches the challenges of rare diseases.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Not specified

Customer Service / Support

Web-Based Support

Training Options

Not specified

Training Options

Not specified

Company Facts

Organization Name

Schrödinger

Company Location

United States

Company Website

www.schrodinger.com

Company Facts

Organization Name

Healx

Date Founded

2014

Company Location

United Kingdom

Company Website

healx.io/technology/

Categories and Features

Drug Discovery

Not specified

Materials Science

Not specified

Molecular Modeling

Not specified

Simulation

Not specified

Categories and Features

Drug Discovery

Not specified

Popular Alternatives

SYNTHIA Retrosynthesis Software Reviews & Ratings

SYNTHIA Retrosynthesis Software

Merck KGaA
5.0 out of 5 stars

Popular Alternatives

alvaModel Reviews & Ratings

alvaModel

Alvascience
BIOVIA Discovery Studio Reviews & Ratings

BIOVIA Discovery Studio

Dassault Systèmes
LiveDesign Reviews & Ratings

LiveDesign

Schrödinger